Señales en vivo de ETON | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (17 may 2024 @ 16:00):

Stats
Volumen de hoy	25 959.00
Volumen promedio	63 919.00
Capitalización de mercado	93.00M
EPS	$0 ( 2024-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-90.50
ATR14	$0.0120 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-13	Gruber James R.	Buy	144 677	Stock Option (Right to buy)
2024-02-13	Adams Jennifer Mckie	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Brynjelsen Sean	Buy	438 633	Stock Option (Right to buy)
2024-02-13	Casamento Charles J	Buy	30 000	Stock Option (Right to buy)
2024-02-13	Krempa David	Buy	144 677	Stock Option (Right to buy)

INSIDER POWER
56.09
Last 96 transactions
Buy: 4 266 352 \| Sell: 3 981 653

Volumen Correlación

Largo: 0.18 (neutral)

Corto: -0.82 (strong negative)

Signal:(47.184) Neutral

Eton Pharmaceuticals Inc Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Eton Pharmaceuticals Inc Correlación - Moneda/Commodity

-0.12
( neutral )

0.40
( neutral )

0.00
( neutral )

-0.38
( neutral )

0.00
( neutral )

-0.52
( weak negative )

Eton Pharmaceuticals Inc Finanzas

Annual	2023
Ingresos:	$31.64M
Beneficio Bruto:	$21.06M (66.56 %)
EPS:	$-0.0365

FY	2023
Ingresos:	$31.64M
Beneficio Bruto:	$21.06M (66.56 %)
EPS:	$-0.0365

FY	2022
Ingresos:	$21.25M
Beneficio Bruto:	$14.32M (67.38 %)
EPS:	$-0.390

FY	2021
Ingresos:	$21.83M
Beneficio Bruto:	$19.21M (87.99 %)
EPS:	$-0.0800

Financial Reports:

No articles found.

Eton Pharmaceuticals Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Eton Pharmaceuticals Inc

Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically important hypotension occurring in the setting of anesthesia. It also offers Alkindi Sprinkle, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; EPRONTIA, a liquid formulation of topiramate; and Alaway Preservative Free, a preservative-free ophthalmic product to treat allergic conjunctivitis. In addition, the company develops Zonisamide Oral Suspension for the treatment of partial on-set seizures; Lamotrigine for Oral Suspension for the treatment of partial on-set seizures; cysteine injection; dehydrated alcohol injection; and Zeneo hydrocortisone autoinjector. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.